HOME >> MEDICINE >> NEWS
Yale receives $10 million to study tobacco use: Research grant comes from three national organizations

New Haven, Conn. -- Yale Medical School researchers will examine why some smokers are resistant to current smoking cessation treatments with a $10 million grant from The National Institute on Drug Abuse (NIDA), the National Cancer Institute (NCI) and The Robert Wood Johnson Foundation.

The five-year grant is part of an $84 million initiative by these three organizations to create national Transdisciplinary Tobacco Use Research Centers (TTURC) for studying tobacco use, new ways to reduce its use and combat its consequences. Led by Principal Investigator Stephanie S. O'Malley, Ph.D., Yale's new TTURC center consists of a multidisciplinary group of scientists conducting five major tobacco research projects.

"The goal of our center is to improve tobacco addiction treatment by studying why current treatments fail and developing new behavioral and drug treatments that address these factors," said O'Malley, professor of psychiatry and director of the Division of Substance Abuse Research at Yale Medical School. "It is critically important that more effective smoking cessation treatments be developed, because most smokers try to quit only once every three to four years."

Despite trends that show declining smoking rates in the general population, rates are declining less in female smokers, smokers with depression and smokers who are heavy drinkers. The five Yale studies will focus on these often-overlooked segments of the smoking population.

"Given societal pressures against smoking, the majority of current smokers are either in the process of quitting or interested in stopping, but many find it difficult to quit and are treatment resistant," said Marina Picciotto, assistant professor of psychiatry and pharmacology at Yale. "In order to treat this group of smokers, we have to increase understanding of alcohol use and depression, which are known factors in treatment failure."

The center grant provides a rare opportunity to examine these risk
'"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
17-Oct-1999


Page: 1 2 3

Related medicine news :

1. UIC professor receives international humanitarian award
2. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
3. Epidemiologist Trichopoulos receives $5.8 million Department of Defense Innovator Award
4. GlaxoSmithKline receives unanimous favorable recommendation by FDA Advisory Committee for Boostrix
5. NYU Child Study Center receives grant from the American Red Cross September 11 recovery program
6. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program
7. American Academy of Neurology program receives Grassroots Award
8. Orqis receives FDA approval to expand clinical trial of Cancion CRS therapy to 40 centers
9. Mayo Clinic Cancer Center receives SPORE grant for brain cancer research from NCI
10. Pfizers antifungal medicine VFEND receives FDA approval
11. Shire receives US FDA approval of EQUETRO (TM) for bipolar disorder

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... April 28, 2017 , ... Getting enough sleep affects much more than energy – it also ... hours without sleep can compromise motor reaction time, which can increase the risk of having ... sharing the following tips from the NSF to help you sleep better and feel better:, ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
(Date:4/28/2017)... ... April 28, 2017 , ... From April ... of Urgent Care Medicine will host industry leaders for the annual spring Convention ... those in the industry adapt to the issues currently affecting urgent care and ...
(Date:4/28/2017)... ... ... and Overseer at The House of Yahweh in Abilene, Texas, has published a new post ... Yisrayl says with so many titles and names for the Creator, it’s hard for ... little Scripture, backed with a lot of research, the truth is undeniable. , “If ...
(Date:4/28/2017)... New York (PRWEB) , ... April 28, 2017 ... ... anti-aging skincare and advanced nutraceutical supplements, through its Nova Skin Sciences ... provides the hydrating benefits of a moisturizer with the power of an anti-aging ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  CVS Pharmacy, the retail division ... new store design to enhance the retail customer ... health-focused products and expanded beauty selections paired with ... discover new offerings. Together with its innovative digital ... the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/20/2017)... Eyevensys, a private biotechnology company ... expression technology that enables the safe, local, sustained production ... wide range of ophthalmic diseases, announces it has received ... Agency (MHRA) to advance its technology into clinical development. ... The EyeCET ...
Breaking Medicine Technology:
Cached News: